Pharmaceuticals

Global Oxycodone Drugs Market Expected To Reach $9.8 Billion By 2030 With 5.7% CAGR

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Oxycodone Drugs Market Be By 2030 Compared To Its 2026 Market Size?

The oxycodone drugs market has demonstrated significant expansion in recent years. It is projected to increase from $5.98 billion in 2025 to $6.38 billion in 2026, with a compound annual growth rate (CAGR) of 6.7%. The historical growth in this market can be attributed to factors such as the high prevalence of moderate to severe pain conditions, the extensive use of opioids in post-operative care, robust hospital demand for injectable analgesics, the proven clinical efficacy of oxycodone, and the limited availability of alternative pain therapies.

The oxycodone drugs market is anticipated to experience robust expansion in the coming years. Its valuation is projected to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected increase during the forecast period is fueled by factors such as more stringent regulations for opioid prescriptions, the rise of controlled-release methods for pain management, a growing incidence of cancer and chronic pain, the proliferation of pain management clinics, and the creation of safer opioid compounds. Key trends anticipated during this period encompass a move towards abuse-deterrent oxycodone formulations, an increased adoption of extended-release pain management treatments, a rising inclination towards administering opioids in hospital settings, a heightened focus on monitoring prescriptions and ensuring compliance, and the broader availability of generic oxycodone products in regulated regions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Strong Drivers Are Impacting The Oxycodone Drugs Market Growth?

The increasing prevalence of orthopedic disorders is anticipated to drive the expansion of the oxycodone drug market in the future. Orthopedic disorders are conditions impacting bones, joints, ligaments, tendons, and muscles, frequently leading to persistent pain, restricted movement, and lasting functional impairments. The escalation of these conditions stems from elements like an aging population, inactive routines, obesity, injuries from sports, and work-related stress. Oxycodone drugs facilitate efficient pain relief for both acute and chronic orthopedic pain, encompassing fractures, joint damage, and recovery after surgery, by targeting pain receptors within the central nervous system. For example, as reported in February 2024 by Arthritis Australia, an Australia-based non-profit organization, projections indicate that in 2025, approximately 212,136 males and 362,137 females are expected to suffer from rheumatoid arthritis (RA), with these figures predicted to increase by 2040 to around 280,040 males and 479,828 females. Consequently, the growing occurrence of orthopedic disorders is fueling the growth of the oxycodone drug market.

What Are The Main Segments Within The Oxycodone Drugs Market Segment Structure?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

Which Trends Are Shaping The Oxycodone Drugs Market?

Leading companies in the oxycodone drug market are concentrating on developing sophisticated abuse-deterrent immediate-release (IR) formulations to lessen the potential for misuse through injection and intranasal routes. These abuse-deterrent IR opioids integrate physical and chemical barriers, making the tablets challenging to crush, dissolve, or alter for non-oral administration, thereby improving patient safety and reducing diversion. For instance, in October 2024, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, obtained FDA approval for ROXYBOND™ (oxycodone hydrochloride) 10 mg immediate-release tablets, which feature patented SentryBond abuse-deterrent technology. This technology is engineered to withstand physical manipulation and chemical extraction, thereby making the tablets difficult to cut, crush, or dissolve for misuse via intranasal or intravenous methods. Consequently, it lowers the risk of abuse while still delivering efficient immediate-release pain relief for patients whose severe pain necessitates opioid therapy when other treatment options prove insufficient.

Who Are The Companies Participating In The Oxycodone Drugs Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Get The Full Oxycodone Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Region Represents The Largest Share Of The Oxycodone Drugs Market?

North America was the largest region in the oxycodone drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oxycodone Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Browse Through More Reports Similar to the Global Oxycodone Drugs Market 2026, By The Business Research Company

Oxycodone Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795